Table 2 HER2+ tumor samples characteristics.
Sample# | Primary site | Stage | ER | ERRB2 Amplicon CN: WGS/ddPCR | ERBB2 Amplicon structure | Segment# |
|---|---|---|---|---|---|---|
m-218 | Colon | IV | N/A | 17/20 | DM | 3 |
m-215 | Breast | IV | − | 22/17 | DM | 6 |
p-103* #1 | Breast | LR | + | 16/43 | DM | 2 |
m-119 | Breast | IV | + | 7/9 | DM | 10 |
p-6890 | Gastric | IV | N/A | 84/106 | ID | 18 |
p-104* #2 | Gastric | IIIA | N/A | 19/33 | ID | 1 |
p-8191 | Gastric | IIIC | N/A | 38/70 | ID | 2 |
p-2 | Breast | IIA | − | 21/67 | ID | 1 |
p-6 | Breast | IIIC | − | 20/70 | ID | 1 |
p-20 | Breast | IIB | − | 15/22 | ID | 1 |
p-22 | Breast | IIA | − | 29/140 | ID | 1 |
p-23 | Breast | LR | − | 29/44 | ID | 1 |
p-108* #2 | Breast | LR | − | 22/20 | ID | 1 |
p-114* | Breast | IIA | − | 39/25 | ID | 3 |
p-216 | Breast | IA | − | 23/27 | ID | 1 |
p-5 #4 | Breast | IIB | + | 16/32 | ID | 1 |
m-12 | Breast | IV | + | 16/14 | ID | 4 |
p-13 | Breast | IIA | + | 19/44 | ID | 1 |
p-27 | Breast | IIA | + | 29/28 | ID | 1 |
p-29* #3 | Breast | IV | + | 30/25 | ID | 7 |
p-30 | Breast | IA | + | 12/21 | ID | 1 |
p-33 #4 | Breast | IIB | + | 26/36 | ID | 1 |
p-112 | Breast | IIA | + | 17/51 | ID | 1 |
p-203 | Breast | IIB | + | 21/24 | ID | 1 |
p-204 | Breast | IIIA | + | 13/9 | ID | 1 |
p-205 | Breast | IIIA | + | 9/12 | ID | 1 |
p-217 | Breast | IV | + | 20/37 | ID | 1 |
p-102* #1 | Breast | IA | ? | 8/22 | ID | 1 |
p-16 | Breast | IIA | − | 15/51 | n/a | 1 |
p-21 | Breast | IIB | − | 9/10 | n/a | 1 |
p-25 | Breast | IIB | − | 15/21 | n/a | 1 |
p-28 | Breast | IA | − | 12/15 | n/a | 1 |
p-106 | Breast | IIA | − | 9/47 | n/a | 1 |
p-115 | Breast | IIA | − | 12/15 | n/a | 1 |
p-214 | Breast | IIA | − | 7/13 | other | 1 |
p-3 | Breast | IIA | + | 13/34 | n/a | 1 |
p-8 | Breast | IA | + | 9/13 | n/a | 1 |
m-11*#3 | Breast | IV | + | 16/126 | n/a | 1 |
p-17 | Breast | IIA | + | 10/90 | n/a | 1 |
p-209 | Breast | IIB | + | 10/17 | other | 1 |
